The Cigna Group announced Monday it has transitioned its entire member-services phone division to a continuous, low-frequency hum. While early trials suggest the 432-hertz vibration is highly effective at terminating incoming calls, health experts caution that more research is needed to determine the sound's long-term impacts on patient mortality.
The nationwide rollout follows a limited pilot study in which policyholders attempting to pre-authorize MRIs were exposed to the sustained drone for up to nine hours. A peer-reviewed paper published last week in the JAMA Health Forum found a strong association between the new humming protocol and patients ultimately deciding to self-fund their surgeries. However, lead authors noted the data was largely self-reported and warned against drawing definitive conclusions from a single cohort of 400,000 enrollees.
While initial acute stress markers were elevated, our clinical data indicates that callers subjected to the frequency eventually reach a state of deep, non-litigious acceptance.
Regulators at the FDA have not yet cleared the audio wave as a safe medical replacement for a human representative actively denying coverage. Independent medical ethicists emphasized the crucial difference between correlation and causation, pointing out that callers weeping into the receiver could be reacting to their own underlying comorbidities rather than the tonal frequency itself.
Pending further peer review of the insurer's methodology, the CDC has issued interim guidance advising policyholders to limit their exposure to the helpline to brief intervals, noting that a soothing mechanical resonance is not an FDA-approved substitute for insulin.